ArticleGeroScience2025
Examining the test-retest reliability of commonly used neuromuscular, morphological, and functional measures in aging adults.
Article in GeroScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Electrical bioimpedance spectral markers distinguish balance ability in older adults without provoking fall risk.Journal of neuroengineering and rehabilitation · 2026Article
- Muscle Imaging Assessments in Sarcopenia: A Statement from China National Center for Orthopedics (NCO) and the East Meets West Action Group of the European Calcified Tissue Society (ECTS).Calcified tissue international · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
The present study aimed at determining the test-retest reliability of commonly used measures in a sample of middle-aged and older participants who presented with a wide range of functional abilities. Participants were middle-aged (40-55 years) and older adults (> 60 years) with- and without mobility limitations, tested both before and after a 4-week period (n = 43). Measures included maximal dynamic (1-RM) and isometric strength, surface EMG (sEMG), peak power, ultrasound-derived muscle size and quality, as well as the performance on the 30-s sit-to-stand, habitual and maximal gait speed, timed up-and-go, stair climb, and 6-min walk tests. Reliability was assessed by means of the intraclass correlation coefficient (ICC), the standard error of measurement (SEM), the minimal detectable change (MDC), and the coefficient of variation (CV). Both dynamic and isometric strength measures displayed excellent reliability (ICCs = 0.96-0.99; CV = 2.2%-7%), whereas muscle size and quality (ICCs = 0.88-0.98; CV = 3.3%-8.7%), functional performance (ICCs = 0.78-0.92; CV = 4.2%-6.8%) and peak power (ICCs = 0.76-0.98; CV = 6.6%-12.8%) results showed good to excellent reliability. Peak power at 80-90% 1‑RM and sEMG measures, on the other hand, showed larger absolute error (CV = 14.4%-18.3% and CV = 14.3%-19.8%, respectively), despite good relative reliability (ICCs = 0.85-0.86). Further results include the comparison between the three subsets of participants included. Our main analysis suggests that most of these measures are sufficiently reliable, even when the two tests are performed a month apart from each other. Our study also supports the notion that, provided that the same equipment and procedures are used, the test-retest reliability of the measures is mostly comparable between the subsets of participants investigated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.